What are ADMA Biologics's profit margins?

ADMA Biologics (ADMA) runs a 61.3% gross margin and a 42.1% operating margin, with a 32.4% net margin.

Where do ADMA Biologics's ratios come from?

Every ratio is computed from ADMA Biologics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

ADMA Biologics ADMA Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Gross margin	57.4%+5.9pp	51.5%+17.0pp	34.4%+11.6pp	22.9%+21.4pp
Operating margin	37.5%+4.9pp	32.6%+24.2pp	8.4%+33.9pp	-25.5%+46.6pp
Net margin	28.8%-17.6pp	46.4%+57.3pp	-10.9%+31.8pp	-42.8%+45.7pp
EBITDA margin	39.1%+4.7pp	34.4%+23.1pp	11.3%+32.3pp	-20.9%+44.4pp
Free cash flow margin	5.5%-20.4pp	25.9%+24.3pp	1.6%+49.2pp	-47.6%+108pp
Returns
Return on equity	35.6%-46.1pp	81.6%+101pp	-19.7%+25.3pp	-45%+17.5pp
Return on assets	26.4%-21.9pp	48.3%+56.7pp	-8.3%+12.8pp	-21.1%+8.5pp
Return on invested capital	38.6%-27.1pp	65.8%+40.6pp	25.2%+70.1pp	-44.9%+6.2pp
Efficiency
Asset turnover	0.9×-0.1×	1×+0.3×	0.8×+0.3×	0.5×+0.2×
Inventory turnover	1.2×-0.1×	1.2×+0.2×	1×+0.2×	0.8×+0.1×
Liquidity
Current ratio	6.7×+0.7×	6×+0.8×	5.2×-1.7×	6.9×0.0×
Quick ratio	3.7×+0.8×	2.9×+1.2×	1.7×-1.0×	2.7×0.0×
Cash ratio	1.3×-0.6×	1.9×+0.8×	1×-1.2×	2.2×+0.5×
Leverage
Debt-to-equity	0.2×-0.1×	0.2×+0.2×	0.1×0.0×	0.1×0.0×
Debt-to-assets	0.1×0.0×	0.2×+0.1×	0×0.0×	0×0.0×
Net debt / EBITDA	-0×+0.1×	-0.1×+1.2×	-1.4×—	——
Interest coverage	26.9×+16.9×	10×+9.1×	0.9×+2.9×	-2×+2.4×
Per Share
Book value per share	$1.95+35.9%	$1.43+138%	$0.60-21.4%	$0.77-24.1%
Valuation
Market capitalization	$4.34B+7.1%	$4.05B+297%	$1.02B+19.2%	$857.1M+210%
Enterprise value	$4.33B+7.4%	$4.03B+311%	$980.85M+25.4%	$782.19M+236%
Price / earnings	29.5×+9.0×	20.5×—	——	——
Price / sales	8.5×-1.0×	9.5×+5.6×	4×-1.6×	5.6×+2.2×
Price / book	9.1×-2.5×	11.6×+4.1×	7.6×+1.9×	5.6×+3.7×
EV / EBITDA	21.7×-5.8×	27.5×-6.1×	33.6×—	——
EV / sales	8.5×-1.0×	9.5×+5.7×	3.8×-1.3×	5.1×+2.2×
Free cash flow yield	0.6%-2.1pp	2.7%+2.3pp	0.4%+9.0pp	-8.6%+37.0pp
Earnings yield	3.4%-1.5pp	4.9%+7.6pp	-2.8%+4.9pp	-7.7%+18.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are ADMA Biologics's profit margins?: ADMA Biologics (ADMA) runs a 61.3% gross margin and a 42.1% operating margin, with a 32.4% net margin.
Where do ADMA Biologics's ratios come from?: Every ratio is computed from ADMA Biologics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.